Lord, Abbett & Co
TNDM icon

Lord, Abbett & Co’s Tandem Diabetes Care TNDM Stock Holding History

Lord, Abbett & Co’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-480,397
Closed -$55.9M – 626
2022
Q1 		$55.9M Buy
480,397
+432
+0.1% +$50.4K 0.15% 197
2021
Q4 		$72.2M Buy
+479,965
New +$64.8M 0.16% 195
2021
Q1 		– Sell
-138,971
Closed -$13.3M – 695
2020
Q4 		$13.3M Sell
138,971
-287,809
-67% -$29.7M 0.04% 482
2020
Q3 		$48.4M Buy
426,780
+24,012
+6% +$2.52M 0.15% 209
2020
Q2 		$39.8M Buy
+402,768
New +$32.1M 0.14% 231
2020
Q1 		– Sell
-217,061
Closed -$12.9M – 703
2019
Q4 		$12.9M Sell
217,061
-595,564
-73% -$36.7M 0.04% 473
2019
Q3 		$47.9M Sell
812,625
-768,995
-49% -$49.1M 0.16% 206
2019
Q2 		$102M Sell
1,581,620
-178,338
-10% -$11.5M 0.33% 65
2019
Q1 		$112M Sell
1,759,958
-51,008
-3% -$2.68M 0.37% 55
2018
Q4 		$68.8M Buy
1,810,966
+365,261
+25% +$12.9M 0.25% 111
2018
Q3 		$61.9M Buy
1,445,705
+952,506
+193% +$33.3M 0.17% 193
2018
Q2 		$10.9M Buy
+493,199
New +$6.06M 0.03% 606
2014
Q3 		– Sell
-15,044
Closed -$2.45M – 1033
2014
Q2 		$2.45M Sell
15,044
-9,868
-40% -$1.68M 0.01% 924
2014
Q1 		$5.5M Buy
24,912
+5,708
+30% +$1.46M 0.01% 779
2013
Q4 		$4.95M Buy
+19,204
New +$4.39M 0.01% 842

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Lord, Abbett & Co's TNDM Position: Q2 2022 in Review

Lord, Abbett & Co sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 480,397 shares — an estimated $55.9M sold.

Lord, Abbett & Co first reported a position in TNDM in Q4 2013 and held it in 15 quarters. The position peaked at $112M in Q1 2019. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Lord, Abbett & Co reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 480,397 Tandem Diabetes Care shares in Q2 2022, an estimated $55.9M.
  • Lord, Abbett & Co first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 15 quarters.
  • Lord, Abbett & Co's Tandem Diabetes Care position peaked at $112M in Q1 2019.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.